Cogent Biosciences, Inc. (COGT) vs Dianthus Therapeutics, Inc. (DNTH)
A side-by-side comparison of Cogent Biosciences, Inc. and Dianthus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$30.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
DNTH
Dianthus Therapeutics, Inc.
$85.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — COGT vs DNTH
growth of $100 · dividends reinvested · last 8yCOGT -50.4% (-8.4%/yr)DNTH -62.1% (-11.4%/yr)COGT compounded faster over this window
COGT DNTH
COGT vs DNTH: by the numbers
- •COGT is the larger company ($5.19B vs $4.78B market cap).
- •Both run net losses; COGT's is the smaller (0.00% vs -1570.85% net margin).
Metrics side by side
Valuation
| Metric | COGT | DNTH |
|---|---|---|
| P/S ratio | N/A | 2508.82 |
| P/B ratio | 11.10 | 4.08 |
Profitability
| Metric | COGT | DNTH |
|---|---|---|
| Gross margin | 0.00% | 96.01% |
| Operating margin | 0.00% | -8739.34% |
| Net margin | 0.00% | -1570.85% |
| ROE | -70.85% | -2.55% |
| ROIC | -50.09% | -18.48% |
Growth (annualized)
| Metric | COGT | DNTH |
|---|---|---|
| Total return CAGR (5Y) | 28.51% | -5.50% |
Frequently asked
- How have COGT and DNTH total returns compared?
- Over the past 5 years, COGT delivered 28.51% and DNTH delivered -5.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.